Jpmorgan Chase & Co »

Vor Biopharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $402k 22k 18.60
2026-03-31 $64k 4.4k 14.70
2025-09-30 $3.8k 78 48.75

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Vor Biopharma

TCG Crossover Management
FMR
Fcpm Iii Services B.v.
BlackRock
VR Adviser
Frazier Life Sciences Management
RA Capital Management
Vanguard Capital Management
Caligan Partners
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Geode Capital Management
Nantahala Capital Management
ADAR1 Capital Management

View all funds holding Vor Biopharma